Australia's sole Q Fever vaccine provider confirms it is prepared to combat the country's rising case numbers
Concerns arose after Cattle Australia called for an urgent $3 million cash injection to bring a new Q Fever vaccine to market on April 29.
CSL Seqirus — manufacturer of the Q-VAX vaccine in Melbourne — confirmed with the Countryman current supply levels would meet current demand.
The zoonotic disease is transmitted predominantly from goats, sheep and cattle and is caused by the bacterium Coxiella burnetii.
It is released through faeces, urine, milk and birth products from infected animals but can spread through the air and dust.
Most people in Australia are unaware of the disease and its potential consequences, including flu-like symptoms, pneumonia and hepatitis.
Victoria experienced five notified outbreaks between August and December last year, with a total of 77 notified cases — more than double the State's average annual incident of the past five years.
This year alone, six cases have been reported to WA Health, while 16 cases were reported in 2024 — spiking in the back end of the year.
The yearly average is eight in Western Australia.
A CSL Seqirus spokesperson said 'normal supply' for the Q-VAX vaccine resumed in February, following a period of limited supply where stock was managed centrally to ensure access for people at the highest risk of infection.
'Approximately 30 to 40,000 Australians are vaccinated against Q fever annually and this is typically driven by workplace vaccinations, public health campaigns and outbreaks of disease,' they said.
'We have been working closely with local Public Health Units in regions with outbreaks to ensure access to vaccination.
'There is always the potential for small increases in demand due to outbreaks and our annual supply planning takes this into account.'
They said a new 'world-class' manufacturing facility near Melbourne Airport is due for completion in 2026 which will manufacture vaccines and antivenoms for Australia and the world.
There are more than 80 clinics offering Q fever vaccinations across the State.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sydney Morning Herald
11 hours ago
- Sydney Morning Herald
Aged 35, I never expected to be diagnosed with bowel cancer
Usually, it can be hours and hours in the waiting room before being admitted. How I wish there had been time to drink the crappy coffee. Instead, I was whisked through emergency within 40 minutes. At that point, I knew something was very wrong. They put this thin tube down my nose and into my stomach. The cramps stopped. The pressure eased on my digestive system. Surgery followed. Biopsies were taken and so came the unimaginable. I had never heard of 'metastasize' or 'Stage 4B'. These terms with which I'd been comfortably unfamiliar were now part of my reality. Translated into plain English, I had aggressive colorectal cancer, and it had spread to my liver and some of the lymph nodes in my abdomen. With no history of cancer in my family, I initially struggled to understand why or how this could happen. I still don't really get it. But young Australians need to get it. Colorectal cancer, also known as bowel cancer, is on the rise for us. While colon caner has declined for over 50s, the risk of being diagnosed before the age of 50 has more than doubled since 2000. Loading Questions flooded my mind. Does this mean I have to have chemotherapy or radiation? How sick am I going to get? Will I survive? I was overcome with panic. My oncologist suggested I try immunotherapy as she had treated similar cases in this way. It harnesses the body's own immune system to fight the disease. Since October last year, I have been undergoing immunotherapy every three weeks. In January, I had my first scan, and the results showed that I was responsive to treatment. I was so relieved I cried. Eleven sessions later and I am continuing to respond to treatment. It's hard to tell exactly how successful it's been as the cancer is located behind several organs, but I'm told it's now visibly smaller. That is about as good as it can be for stage four. There is the physical toll – crippling fatigue and body aches. A supercharged immune system can play havoc on your adrenal glands and thyroid. And then there's the mental anguish. There are so many unknowns. My oncologist said: 'I don't have a timeline for you. I am not going to give you expectations. I am hoping this works, but I don't know.' I think of my husband, Joseph, my best friend. My beautiful rescue greyhound, Seven. They are everything to me, along with my friends and family. I have no choice but to keep fighting. My career in the corporate world has in some ways given me the skills to keep going – remaining calm, coping under pressure and asking the right questions. Loading Thankfully, my employer has reduced my workload, allowing me to focus on my health, rather than worrying about job security. My colleagues have shown incredible kindness, always making sure I am getting enough rest and checking on my wellbeing. In many ways, work has become a refuge – a semblance of normalcy amid the chaos and uncertainty. But Joseph has been my rock. Managing a work schedule around my appointments and being there by my side, every step of the way. Not everyone in my position has that, and I am so thankful. Seven has also kept me calm and gives me plenty of cuddles. A pet is a fantastic companion during tough times. As I continue navigating this very strange odyssey, I do have some advice I want to pass on. You know your body better than anyone else. If it feels off, if you know something is not quite right, trust your instincts. It was only after I got a second opinion that I started to get more answers. Don't stop at anything when it comes to your health. And for those in a similar position – cancer is a marathon, not a sprint. Having a good network of runners around you is crucial. I am lucky in that sense.
The Age
11 hours ago
- The Age
Aged 35, I never expected to be diagnosed with bowel cancer
Usually, it can be hours and hours in the waiting room before being admitted. How I wish there had been time to drink the crappy coffee. Instead, I was whisked through emergency within 40 minutes. At that point, I knew something was very wrong. They put this thin tube down my nose and into my stomach. The cramps stopped. The pressure eased on my digestive system. Surgery followed. Biopsies were taken and so came the unimaginable. I had never heard of 'metastasize' or 'Stage 4B'. These terms with which I'd been comfortably unfamiliar were now part of my reality. Translated into plain English, I had aggressive colorectal cancer, and it had spread to my liver and some of the lymph nodes in my abdomen. With no history of cancer in my family, I initially struggled to understand why or how this could happen. I still don't really get it. But young Australians need to get it. Colorectal cancer, also known as bowel cancer, is on the rise for us. While colon caner has declined for over 50s, the risk of being diagnosed before the age of 50 has more than doubled since 2000. Loading Questions flooded my mind. Does this mean I have to have chemotherapy or radiation? How sick am I going to get? Will I survive? I was overcome with panic. My oncologist suggested I try immunotherapy as she had treated similar cases in this way. It harnesses the body's own immune system to fight the disease. Since October last year, I have been undergoing immunotherapy every three weeks. In January, I had my first scan, and the results showed that I was responsive to treatment. I was so relieved I cried. Eleven sessions later and I am continuing to respond to treatment. It's hard to tell exactly how successful it's been as the cancer is located behind several organs, but I'm told it's now visibly smaller. That is about as good as it can be for stage four. There is the physical toll – crippling fatigue and body aches. A supercharged immune system can play havoc on your adrenal glands and thyroid. And then there's the mental anguish. There are so many unknowns. My oncologist said: 'I don't have a timeline for you. I am not going to give you expectations. I am hoping this works, but I don't know.' I think of my husband, Joseph, my best friend. My beautiful rescue greyhound, Seven. They are everything to me, along with my friends and family. I have no choice but to keep fighting. My career in the corporate world has in some ways given me the skills to keep going – remaining calm, coping under pressure and asking the right questions. Loading Thankfully, my employer has reduced my workload, allowing me to focus on my health, rather than worrying about job security. My colleagues have shown incredible kindness, always making sure I am getting enough rest and checking on my wellbeing. In many ways, work has become a refuge – a semblance of normalcy amid the chaos and uncertainty. But Joseph has been my rock. Managing a work schedule around my appointments and being there by my side, every step of the way. Not everyone in my position has that, and I am so thankful. Seven has also kept me calm and gives me plenty of cuddles. A pet is a fantastic companion during tough times. As I continue navigating this very strange odyssey, I do have some advice I want to pass on. You know your body better than anyone else. If it feels off, if you know something is not quite right, trust your instincts. It was only after I got a second opinion that I started to get more answers. Don't stop at anything when it comes to your health. And for those in a similar position – cancer is a marathon, not a sprint. Having a good network of runners around you is crucial. I am lucky in that sense.
The Advertiser
20 hours ago
- The Advertiser
At-home drug test offers workers more autonomy
A growing drug problem in Australian workplaces is prompting a shift in how businesses manage safety and wellbeing, with a new push for discreet, at-home drug testing aimed at preventing accidents before they happen. And the broader trend is worrying. According to a recent United Nations report, Australians and New Zealanders are among the world's highest per-capita users of cocaine and ecstasy, with cannabis use also well above the global average. While many users are occasional, the UN warns of growing trafficking networks and drug availability across the region - raising concerns about how those substances flow into everyday settings such as the workplace. With one in nine Australian workers admitting to being under the influence of illicit drugs while on the job, the risks to safety, productivity and mental health are mounting. In high-risk sectors such as transport, construction and hospitality, even a momentary lapse in judgment can have deadly consequences. "The risks are real in terms of safety, productivity and wellbeing - they are all on the line," said Matthew Salihi, CEO of Touch Biotechnology, which is promoting a new range of portable, non-invasive self-testing kits. Instead of relying solely on workplace drug screenings after an incident has already occurred, the initiative encourages employees to test themselves voluntarily - at home, in private - before heading into work. "The whole concept is about self-regulation and personal responsibility," Mr Salihi told AAP. "It gives people a private way to check themselves before a shift, after a weekend, or during recovery. No pressure, no judgment … just a tool to help them stay in control and do the right thing before it becomes a problem." The tests work much the same as COVID-19 kits: simple saliva or urine samples return results within minutes, indicating whether substances including cannabis, cocaine or methamphetamines are present. Mr Salihi said the purpose was prevention, not surveillance. It was not about judging people for what they did in their personal life - it was about making sure they turned up to work clean and safe, he said. Drug use among workers is not just common but often tied to deeper struggles. "For many people, it's not about partying or coping, as such. People turn to drugs to manage the stress, exhaustion and emotional pressure," Mr Salihi said. "It's often a mental health issue, to be honest. The drug use is just a symptom." He said self-testing offered a crucial moment for early intervention before things spiralled. While some critics might argue self-testing reduces visibility for employers, Mr Salihi sees it differently. "Self-testing actually empowers people … and when it's part of a broader program with clear policies, education and support, it opens the door to more honest conversation, not less," he said. Drug-related absenteeism and safety incidents are costing Australian businesses more than $5 billion a year. In industries such as trucking, where stimulant use is not uncommon, the margin for error is slim. A small mistake behind the wheel could spell disaster, Salihi said. "That's what we're trying to help eliminate." Lifeline 13 11 14 beyondblue 1300 22 4636 A growing drug problem in Australian workplaces is prompting a shift in how businesses manage safety and wellbeing, with a new push for discreet, at-home drug testing aimed at preventing accidents before they happen. And the broader trend is worrying. According to a recent United Nations report, Australians and New Zealanders are among the world's highest per-capita users of cocaine and ecstasy, with cannabis use also well above the global average. While many users are occasional, the UN warns of growing trafficking networks and drug availability across the region - raising concerns about how those substances flow into everyday settings such as the workplace. With one in nine Australian workers admitting to being under the influence of illicit drugs while on the job, the risks to safety, productivity and mental health are mounting. In high-risk sectors such as transport, construction and hospitality, even a momentary lapse in judgment can have deadly consequences. "The risks are real in terms of safety, productivity and wellbeing - they are all on the line," said Matthew Salihi, CEO of Touch Biotechnology, which is promoting a new range of portable, non-invasive self-testing kits. Instead of relying solely on workplace drug screenings after an incident has already occurred, the initiative encourages employees to test themselves voluntarily - at home, in private - before heading into work. "The whole concept is about self-regulation and personal responsibility," Mr Salihi told AAP. "It gives people a private way to check themselves before a shift, after a weekend, or during recovery. No pressure, no judgment … just a tool to help them stay in control and do the right thing before it becomes a problem." The tests work much the same as COVID-19 kits: simple saliva or urine samples return results within minutes, indicating whether substances including cannabis, cocaine or methamphetamines are present. Mr Salihi said the purpose was prevention, not surveillance. It was not about judging people for what they did in their personal life - it was about making sure they turned up to work clean and safe, he said. Drug use among workers is not just common but often tied to deeper struggles. "For many people, it's not about partying or coping, as such. People turn to drugs to manage the stress, exhaustion and emotional pressure," Mr Salihi said. "It's often a mental health issue, to be honest. The drug use is just a symptom." He said self-testing offered a crucial moment for early intervention before things spiralled. While some critics might argue self-testing reduces visibility for employers, Mr Salihi sees it differently. "Self-testing actually empowers people … and when it's part of a broader program with clear policies, education and support, it opens the door to more honest conversation, not less," he said. Drug-related absenteeism and safety incidents are costing Australian businesses more than $5 billion a year. In industries such as trucking, where stimulant use is not uncommon, the margin for error is slim. A small mistake behind the wheel could spell disaster, Salihi said. "That's what we're trying to help eliminate." Lifeline 13 11 14 beyondblue 1300 22 4636 A growing drug problem in Australian workplaces is prompting a shift in how businesses manage safety and wellbeing, with a new push for discreet, at-home drug testing aimed at preventing accidents before they happen. And the broader trend is worrying. According to a recent United Nations report, Australians and New Zealanders are among the world's highest per-capita users of cocaine and ecstasy, with cannabis use also well above the global average. While many users are occasional, the UN warns of growing trafficking networks and drug availability across the region - raising concerns about how those substances flow into everyday settings such as the workplace. With one in nine Australian workers admitting to being under the influence of illicit drugs while on the job, the risks to safety, productivity and mental health are mounting. In high-risk sectors such as transport, construction and hospitality, even a momentary lapse in judgment can have deadly consequences. "The risks are real in terms of safety, productivity and wellbeing - they are all on the line," said Matthew Salihi, CEO of Touch Biotechnology, which is promoting a new range of portable, non-invasive self-testing kits. Instead of relying solely on workplace drug screenings after an incident has already occurred, the initiative encourages employees to test themselves voluntarily - at home, in private - before heading into work. "The whole concept is about self-regulation and personal responsibility," Mr Salihi told AAP. "It gives people a private way to check themselves before a shift, after a weekend, or during recovery. No pressure, no judgment … just a tool to help them stay in control and do the right thing before it becomes a problem." The tests work much the same as COVID-19 kits: simple saliva or urine samples return results within minutes, indicating whether substances including cannabis, cocaine or methamphetamines are present. Mr Salihi said the purpose was prevention, not surveillance. It was not about judging people for what they did in their personal life - it was about making sure they turned up to work clean and safe, he said. Drug use among workers is not just common but often tied to deeper struggles. "For many people, it's not about partying or coping, as such. People turn to drugs to manage the stress, exhaustion and emotional pressure," Mr Salihi said. "It's often a mental health issue, to be honest. The drug use is just a symptom." He said self-testing offered a crucial moment for early intervention before things spiralled. While some critics might argue self-testing reduces visibility for employers, Mr Salihi sees it differently. "Self-testing actually empowers people … and when it's part of a broader program with clear policies, education and support, it opens the door to more honest conversation, not less," he said. Drug-related absenteeism and safety incidents are costing Australian businesses more than $5 billion a year. In industries such as trucking, where stimulant use is not uncommon, the margin for error is slim. A small mistake behind the wheel could spell disaster, Salihi said. "That's what we're trying to help eliminate." Lifeline 13 11 14 beyondblue 1300 22 4636 A growing drug problem in Australian workplaces is prompting a shift in how businesses manage safety and wellbeing, with a new push for discreet, at-home drug testing aimed at preventing accidents before they happen. And the broader trend is worrying. According to a recent United Nations report, Australians and New Zealanders are among the world's highest per-capita users of cocaine and ecstasy, with cannabis use also well above the global average. While many users are occasional, the UN warns of growing trafficking networks and drug availability across the region - raising concerns about how those substances flow into everyday settings such as the workplace. With one in nine Australian workers admitting to being under the influence of illicit drugs while on the job, the risks to safety, productivity and mental health are mounting. In high-risk sectors such as transport, construction and hospitality, even a momentary lapse in judgment can have deadly consequences. "The risks are real in terms of safety, productivity and wellbeing - they are all on the line," said Matthew Salihi, CEO of Touch Biotechnology, which is promoting a new range of portable, non-invasive self-testing kits. Instead of relying solely on workplace drug screenings after an incident has already occurred, the initiative encourages employees to test themselves voluntarily - at home, in private - before heading into work. "The whole concept is about self-regulation and personal responsibility," Mr Salihi told AAP. "It gives people a private way to check themselves before a shift, after a weekend, or during recovery. No pressure, no judgment … just a tool to help them stay in control and do the right thing before it becomes a problem." The tests work much the same as COVID-19 kits: simple saliva or urine samples return results within minutes, indicating whether substances including cannabis, cocaine or methamphetamines are present. Mr Salihi said the purpose was prevention, not surveillance. It was not about judging people for what they did in their personal life - it was about making sure they turned up to work clean and safe, he said. Drug use among workers is not just common but often tied to deeper struggles. "For many people, it's not about partying or coping, as such. People turn to drugs to manage the stress, exhaustion and emotional pressure," Mr Salihi said. "It's often a mental health issue, to be honest. The drug use is just a symptom." He said self-testing offered a crucial moment for early intervention before things spiralled. While some critics might argue self-testing reduces visibility for employers, Mr Salihi sees it differently. "Self-testing actually empowers people … and when it's part of a broader program with clear policies, education and support, it opens the door to more honest conversation, not less," he said. Drug-related absenteeism and safety incidents are costing Australian businesses more than $5 billion a year. In industries such as trucking, where stimulant use is not uncommon, the margin for error is slim. A small mistake behind the wheel could spell disaster, Salihi said. "That's what we're trying to help eliminate." Lifeline 13 11 14 beyondblue 1300 22 4636
